Nasdaq · Healthcare
TETRA TECH INC (TTEK)
As-reported financials and recent SEC filings for TETRA TECH INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.44B
Net income
$247.9M
Net margin
4.6%
Diluted EPS
$0.93
ROE
13.9%
P/E (TTM)
17.5×
Market cap
$7.59B
Debt / equity
0.4×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.44B | $5.20B | $4.52B | $3.50B | $3.21B |
| Gross profit | $4.62B | $4.32B | $3.75B | — | — |
| Operating income | $408.4M | $500.7M | $358.1M | $340.4M | $278.7M |
| Net income | $247.9M | $333.4M | $273.5M | $263.2M | $232.8M |
| Diluted EPS | $0.93 | $1.23 | $1.02 | $0.97 | $0.85 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-05
View on EDGAR →42026-05-15
View on EDGAR →10-Q2026-05-01
View on EDGAR →SCHEDULE 13G2026-04-30
View on EDGAR →8-K2026-04-29
View on EDGAR →42026-04-28
View on EDGAR →32026-04-03
View on EDGAR →SCHEDULE 13G/A2026-03-27
View on EDGAR →Go deeper on TTEK
Search TETRA TECH INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.